CUSIP 31189P102COMFATEQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
142 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Redmile Group, LLC | 12.87M | $12.65M | 0 | Held |
| 2 | Blackrock, Inc. | 10.18M | $10.00M | −504.2K | Reduced |
| 3 | Vanguard Group Inc | 8.97M | $8.82M | +172.9K | Added |
| 4 | Johnson & Johnson | 3.38M | $3.32M |
| 0 |
| Held |
| 5 | Geode Capital Management, LLC | 2.47M | $2.43M | −61.9K | Reduced |
| 6 | Renaissance Technologies LLC | 2.36M | $2.32M | +1.10M | Added |
| 7 | State Street Corp | 2.27M | $2.23M | −151.9K | Reduced |
| 8 | Two Sigma Investments, LP | 1.73M | $1.70M | +833.3K | Added |
| 9 | Vestal Point Capital, LP | 1.73M | $1.69M | −790.0K | Reduced |
| 10 | Two Sigma Advisers, LP | 1.65M | $1.62M | +644.3K | Added |
See every fund holding Fate Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders